Currently, there are 1.36B common shares owned by the public and among those 1.21B shares have been available to trade.
The company’s stock has a 5-day price change of -3.60% and 6.94% over the past three months. KDP shares are trading 5.98% year to date (YTD), with the 12-month market performance up to 5.26% higher. It has a 12-month low price of $30.12 and touched a high of $38.28 over the same period. KDP has an average intraday trading volume of 14.14 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.19%, 0.07%, and 0.13% respectively.
Institutional ownership of Keurig Dr Pepper Inc (NASDAQ: KDP) shares accounts for 80.87% of the company’s 1.36B shares outstanding.
It has a market capitalization of $46.23B and a beta (3y monthly) value of 0.53. The stock’s trailing 12-month PE ratio is 30.83, while the earnings-per-share (ttm) stands at $1.10. The company has a PEG of 4.83 and a Quick Ratio of 0.29 with the debt-to-equity ratio at 0.72. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.46% over the week and 2.76% over the month.
Analysts forecast that Keurig Dr Pepper Inc (KDP) will achieve an EPS of 0.49 for the current quarter, 0.54 for the next quarter and 2.17 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.47 while analysts give the company a high EPS estimate of 0.47. Comparatively, EPS for the current quarter was 0.45 a year ago. Earnings per share for the fiscal year are expected to increase by 6.11%, and 6.64% over the next financial year. EPS should grow at an annualized rate of 6.38% over the next five years, compared to 3.57% over the past 5-year period.
Looking at the support for the KDP, a number of firms have released research notes about the stock. HSBC Securities stated their Buy rating for the stock in a research note on April 25, 2025, with the firm’s price target at $42. Argus coverage for the Keurig Dr Pepper Inc (KDP) stock in a research note released on April 16, 2025 offered a Buy rating with a price target of $40. Piper Sandler was of a view on April 09, 2025 that the stock is Overweight, while Morgan Stanley gave the stock Overweight rating on April 01, 2025, issuing a price target of $40. Piper Sandler on their part issued Neutral rating on January 07, 2025.
